They're in Switzerland and Germany.
Two more manufacturing sites have been approved by European health regulators for the BioNtech/Pfizer Covid vaccine.
The sites in Germany and Switzerland are expected to support the continued supply of the vaccine in the European Union.
According to the EMA, the sites can become operational immediately.
EMA has approved additional manufacturing sites for the production of Comirnaty, the #COVID19vaccine developed by BioNTech and Pfizer. https://t.co/kFXSVB6rRn#VaccinesWork #CovidVaccines pic.twitter.com/sKSBaBkrzu
— EU Medicines Agency (@EMA_News) June 22, 2021

Social Media Could Change Forever If Meta Loses US Legal Battle, Says Experts
Efforts To Achieve Peace Plan For Gaza Continue As US Meet Middle East Mediators
US Military Fire On Ship In Gulf Of Oman
Over 250 People Now Confirmed Dead Following Devastating Earthquake In Colombia
Rescue Operation Continues After 160 Dead In Colombian Earthquake
Six Killed In School Shooting Near Bangkok In Thailand
Reports Of Iran And Oman Working Towards Deal To Reopen Strait Of Hormuz
EU Home Affairs Ministers Meet To Discuss Protection Of Borders From Illegal Migration